OTCMKTS:CRTPF (OTCMKTS:CRTPF)’s stock price rose 5% during trading on Monday . The stock traded as high as $3.05 and last traded at $3.05, approximately 3,500 shares were traded during mid-day trading. A decline of 82% from the average daily volume of 19,119 shares. The stock had previously closed at $2.90.


Cardiol Therapeutics Inc, a biotechnology company, engages in the research and commercial development of proprietary drug formulations for the treatment of heart failure and cancer. The company develops CTX01, a proprietary formulation of pharmaceutical cannabidiol for the treatment of heart failure with preserved ejection fraction; CTX02, a proprietary formulation of methotrexate for the treatment of heart failure; and CTX03 is a proprietary nanoformulation of encapsulated Cyclosporine A for the treatment of heart failure.

Featured Story: Monthly Dividend Stocks

Receive News & Ratings for OTCMKTS:CRTPF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OTCMKTS:CRTPF and related companies with MarketBeat.com's FREE daily email newsletter.